TSR3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of the TSR3 protein, a ribosomal biogenesis factor involved in the maturation of ribosomal RNA (rRNA). TSR3 is responsible for modifying 18S rRNA, which is a critical component of the small subunit of the ribosome. The proper maturation of rRNA is essential for ribosome assembly, a process that is fundamental to protein synthesis in all cells. TSR3 inhibitors act by binding to the active or regulatory sites of the TSR3 protein, thereby blocking its ability to carry out modifications on the precursor rRNA. This disruption of rRNA processing interferes with ribosome formation, ultimately impacting protein translation and cellular metabolism.
Chemically, TSR3 inhibitors are often designed to be highly specific, focusing on the structural features unique to the TSR3 protein. These inhibitors might interact directly with the active site where the rRNA modification occurs or with allosteric sites that affect TSR3's function. The design of these compounds requires a detailed understanding of the three-dimensional structure of TSR3 and its interaction with rRNA. Given the complexity of ribosome biogenesis, TSR3 inhibitors must be precise in their targeting to avoid affecting other proteins involved in this intricate process. Researchers study TSR3 inhibitors not only to understand the function of TSR3 in ribosomal RNA maturation but also to gain insights into the broader mechanisms of ribosome assembly. By inhibiting TSR3, these compounds provide a useful tool for investigating the molecular steps involved in the biogenesis of the ribosomal small subunit and how it contributes to cellular protein synthesis.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a kinase involved in cell growth and proliferation, thereby affecting protein synthesis and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1/2, which interrupts the MAPK/ERK pathway, affecting proteins that rely on this pathway for activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, disrupting the PI3K/AKT pathway and affecting downstream protein activity, including those involved in survival and proliferation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that alters chromatin structure and gene expression, affecting protein regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, altering stress response pathways and affecting protein activity linked to this signaling route. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Inhibits calmodulin, which affects calcium signal transduction and proteins that are regulated by calcium/calmodulin-dependent pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, interfering with the MAPK/ERK pathway, thereby affecting the activity of proteins regulated by this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which alters the JNK signaling pathway, affecting the activity of proteins that are modulated by this pathway. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits SERCA, disrupting calcium homeostasis and affecting proteins that are regulated by calcium-dependent pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibits the proteasome, preventing protein degradation and affecting the function of proteins that rely on proteasomal degradation for regulation. | ||||||